Pan-Cancer Analysis of GALNT6 with Potential Implications for Prognosis and Tumor Microenvironment in Human Cancer Based on Bioinformatics and qPCR Verification

被引:0
作者
Shao, Yue [1 ]
Li, Rong [1 ]
Chen, Guangmei [1 ]
Zhang, Lichuan [1 ]
机构
[1] Dalian Univ, Affiliated Zhongshan Hosp, Dept Resp Med, Dalian 116001, Peoples R China
来源
INTERNATIONAL JOURNAL OF GENERAL MEDICINE | 2024年 / 17卷
关键词
GALNT6; pan-cancer; survival analysis; mutation; immune infiltration; functional mechanisms; N-ACETYLGALACTOSAMINYLTRANSFERASE; 6; GENE-EXPRESSION; O-GLYCOSYLATION; METASTASIS; BURDEN; CELL; IMMUNOTHERAPY; BIOMARKER; GENOMICS; FAMILY;
D O I
10.2147/IJGM.S459953
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: We explored the expression and prognostic value of GALNT6 and the tumor microenvironment of pan -cancer in humans. Methods: In this study, we explored the expression pattern of GALNT6 pan -cancer across multiple databases. The prognostic value GALNT6 was evaluated using the Kaplan-Meier method. The types and numbers of GALNT6 gene alterations were exhibited using the cBio Cancer Genomics Portal. The correlations between GALNT6 expression and immune infiltration in cancers were analyzed using the database Tumor Immune Estimation Resource 2. We also used the Kyoto Encyclopedia of Genes and Genomes pathway and Gene Ontology analysis to investigate the molecular mechanisms of the GALNT6 gene in tumorigenesis. The expression of GALNT6 was also further verified by qPCR in lung adenocarcinoma tissues. Results: In general, compared with normal tissue, tumor tissue had a higher expression level of GALNT6. GALNT6 showed a protective effect in colon carcinoma and other cancers; however, a high expression level of GALNT6 was detrimental to survival in bladder cancer and in pheochromocytoma and paraganglioma. Mutation, amplification, and deep deletion were the three main types of GALNT6 mutations in tumors. There was a significant positive correlation between GALNT6 expression and immune infiltration CD8+ T -cells in skin cutaneous melanoma metastasis, based on most of the algorithms used. Moreover, protein processing- and glycoprotein metabolic -associated functions were involved in the functional mechanisms of GALNT6. Conclusion: This first pan -cancer study offers a relatively comprehensive understanding of the oncogenic roles of GALNT6 across different cancer types.
引用
收藏
页码:2187 / 2201
页数:15
相关论文
共 46 条
  • [1] Clathrin-mediated endocytosis of MUC1 is modulated by its glycosylation state
    Altschuler, Y
    Kinlough, CL
    Poland, PA
    Bruns, JB
    Apodaca, G
    Weisz, OA
    Hughey, RP
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2000, 11 (03) : 819 - 831
  • [2] Andrea N, 2020, Eur Urol, V78, P77, DOI [10.1016/j.eururo.2019.04.019, DOI 10.1016/J.EURURO.2019.04.019]
  • [3] Cloning and characterization of a close homologue of human UDP-N-acetyl-α-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-T3, designated GalNAc-T6 -: Evidence for genetic but not functional redundancy
    Bennett, EP
    Hassan, H
    Mandel, U
    Hollingsworth, MA
    Akisawa, N
    Ikematsu, Y
    Merkx, G
    van Kessel, AG
    Olofsson, S
    Clausen, H
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (36) : 25362 - 25370
  • [4] Immunolocalisation of members of the polypeptide N-acetylgalactosaminyl transferase (ppGalNAc-T) family is consistent with biologically relevant altered cell surface glycosylation in breast cancer
    Brooks, Susan A.
    Carter, Tracey M.
    Bennett, Eric P.
    Clausen, Henrik
    Mandel, Ulla
    [J]. ACTA HISTOCHEMICA, 2007, 109 (04) : 273 - 284
  • [5] Years of life lost as a measure of cancer burden on a national level
    Brustugun, O. T.
    Moller, B.
    Helland, A.
    [J]. BRITISH JOURNAL OF CANCER, 2014, 111 (05) : 1014 - 1020
  • [6] The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
    Cerami, Ethan
    Gao, Jianjiong
    Dogrusoz, Ugur
    Gross, Benjamin E.
    Sumer, Selcuk Onur
    Aksoy, Buelent Arman
    Jacobsen, Anders
    Byrne, Caitlin J.
    Heuer, Michael L.
    Larsson, Erik
    Antipin, Yevgeniy
    Reva, Boris
    Goldberg, Arthur P.
    Sander, Chris
    Schultz, Nikolaus
    [J]. CANCER DISCOVERY, 2012, 2 (05) : 401 - 404
  • [7] UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
    Chandrashekar, Darshan S.
    Bashel, Bhuwan
    Balasubramanya, Sai Akshaya Hodigere
    Creighton, Chad J.
    Ponce-Rodriguez, Israel
    Chakravarthi, Balabhadrapatruni V. S. K.
    Varambally, Sooryanarayana
    [J]. NEOPLASIA, 2017, 19 (08): : 649 - 658
  • [8] Turning foes to friends: targeting cancer-associated fibroblasts
    Chen, Xueman
    Song, Erwei
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2019, 18 (02) : 99 - 115
  • [9] Tumour mutational burden as a biomarker for immunotherapy: Current data and emerging concepts
    Fumet, Jean-David
    Truntzer, Caroline
    Yarchoan, Mark
    Ghiringhelli, Francois
    [J]. EUROPEAN JOURNAL OF CANCER, 2020, 131 : 40 - 50
  • [10] Hallmarks of Cancer: New Dimensions
    Hanahan, Douglas
    [J]. CANCER DISCOVERY, 2022, 12 (01) : 31 - 46